Telemedicine allows quantitative measuring of olfactory dysfunction in COVID-19
Allergy
.
2021 Mar;76(3):868-870.
doi: 10.1111/all.14467.
Epub 2020 Jul 20.
Authors
Ludger Klimek
1
2
,
Jan Hagemann
3
,
Ali Alali
1
,
Magdalena Spielhaupter
1
,
Tilman Huppertz
3
,
Karl Hörmann
4
,
Sabine Stielow
5
,
Laura Freudelsperger
3
,
Christoph Matthias
3
Affiliations
1
Centre for Rhinology and Allergology, Wiesbaden, Germany.
2
Universitätsmedizin der Johannes Gutenberg-Universität Mainz.
3
Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center, Mainz, Germany.
4
Mannheim University Hospital, Mannheim, Germany.
5
COVID-19 Test Center Wiesbaden, Wiesbaden, Germany.
PMID:
32569393
PMCID:
PMC7361410
DOI:
10.1111/all.14467
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Adult
COVID-19 / complications*
Female
Humans
Male
Olfaction Disorders / diagnosis*
SARS-CoV-2*
Telemedicine*
Grants and funding
HSP 2020/03-1/Hessische Stiftung für Prävention, Wiesbaden, Germany